Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Andrus Ltd.
In immuno-oncology and beyond, Chinese investors are setting their sights on new targets in the biopharma arena.
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced May and June 2014.